Literature DB >> 15673505

Effect of phage infection on toxin production by Clostridium difficile.

Shan Goh1, Barbara J Chang1, Thomas V Riley1.   

Abstract

Infection with Clostridium difficile and subsequent production of toxins A and B may result in C. difficile-associated diarrhoea and pseudomembranous colitis in hospital patients. The effect of four temperate phages, obtained by induction of clinical C. difficile isolates, on toxin production by C. difficile was determined. None of these phages converted a lysogenized non-toxigenic C. difficile strain to toxin production. One of the accessory toxin genes, tcdE, was detected in three phages, phiC2, phiC6 and phiC8; however, the non-repeating regions of tcdA and tcdB encoding the enzymic domains were not carried on phage DNA. Phage infection of toxigenic strains increased toxin B production in four of six lysogens, although the level of tcdB transcription as determined by real-time RT-PCR was not significantly altered. However, levels of toxin A transcription in two lysogens were significantly altered without any corresponding differences in toxin A production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673505     DOI: 10.1099/jmm.0.45821-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  31 in total

1.  Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficile.

Authors:  Sabine Nuding; Tina Frasch; Martin Schaller; Eduard F Stange; Lutz T Zabel
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

2.  Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens.

Authors:  Ognjen Sekulovic; Mathieu Meessen-Pinard; Louis-Charles Fortier
Journal:  J Bacteriol       Date:  2011-03-25       Impact factor: 3.490

3.  In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119.

Authors:  Govind Revathi; Joe A Fralick; Rial D Rolfe
Journal:  Anaerobe       Date:  2011-06-02       Impact factor: 3.331

4.  Prophage carriage and diversity within clinically relevant strains of Clostridium difficile.

Authors:  Jinyu Shan; Krusha V Patel; Peter T Hickenbotham; Janet Y Nale; Katherine R Hargreaves; Martha R J Clokie
Journal:  Appl Environ Microbiol       Date:  2012-06-15       Impact factor: 4.792

5.  Bacteriophage-mediated toxin gene regulation in Clostridium difficile.

Authors:  Revathi Govind; Govindsamy Vediyappan; Rial D Rolfe; Bruno Dupuy; Joe A Fralick
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

6.  Morphological and genetic diversity of temperate phages in Clostridium difficile.

Authors:  Louis-Charles Fortier; Sylvain Moineau
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

7.  Genomic organization and molecular characterization of Clostridium difficile bacteriophage PhiCD119.

Authors:  Revathi Govind; Joe A Fralick; Rial D Rolfe
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

8.  Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins.

Authors:  Ognjen Sekulovic; Julian R Garneau; Audrey Néron; Louis-Charles Fortier
Journal:  Appl Environ Microbiol       Date:  2014-02-14       Impact factor: 4.792

Review 9.  Clostridioides difficile phage biology and application.

Authors:  Joshua Heuler; Louis-Charles Fortier; Xingmin Sun
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

10.  Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains.

Authors:  Janet Y Nale; Jinyu Shan; Peter T Hickenbotham; Warren N Fawley; Mark H Wilcox; Martha R J Clokie
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.